Skip to main content

Table 2 Clinical characteristics at the time of recrudescent and new infection compared to participants at the end of the study without recurrent infection

From: Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment

  Distribution Odds ratio (95% CI) univariate P value Odds ratio (95% CI) Multivariate Recrudescent vs. new P value
Proportion (%)
Fever
No 11/277(3.9) Referent    
Recrudescent 26/119 (21.8) 6.8 (3.2-14.3) <.001 Referent  
New 13/84 (15.4) 4.4 (1.9-10.3) .001 .6 (.2-1.5) .27
Anaemia
No 137/275 (49.8) Referent    
Recrudescent 81/117 (69.2) 2.3 (1.4-3.7) .001 Referent  
New 54/83 (65.1) 1.9 (1.1-3.2) .017 1.5 (.7-3.2) .34
  Mean (95% CI)    
Change in haemoglobin
No .9 (.8-1.2)    
Recrudescent .7 (.4-1.0) .2 Referent  
New 1.2 (.7-1.6) .4 1.3 (1.1-1.6) .01
Multiplicity of infection
No N/A    
Recrudescent 2.7 (2.3-3.0)   Referent  
New 2.3 (2.1-2.6) .1 .8 (.6-1.0) .05